Search research articles
Contact Us
Filters
Showing results (101-110 of 104) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 104 results.
Science Signaling
|
October 31, 2023
Redox-active endosomes mediate α5β1 integrin signaling and promote chondrocyte matrix metalloproteinase production in osteoarthritis
Michael Z Miao, Qian Peter Su, Yang Cui, et al.
ACS Nano
|
October 30, 2023
Integrating Anion-π<sup>+</sup> Interaction and Crowded Conformation to Develop Multifunctional NIR AIEgen for Effective Tumor Theranostics via Hippo-YAP Pathway
Shiping Yang, Hongchi Yu, Junkai Liu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 1, 1997
Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections: results of a randomized, controlled clinical trial
J T Li, Y Lu, J Hou, et al.
Nature Biotechnology
|
September 25, 2023
Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses
Menglin Wang, Benoit Rousseau, Kunyu Qiu, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 104) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 104 results.
Science Signaling
|
October 31, 2023
Redox-active endosomes mediate α5β1 integrin signaling and promote chondrocyte matrix metalloproteinase production in osteoarthritis
Michael Z Miao, Qian Peter Su, Yang Cui, et al.
ACS Nano
|
October 30, 2023
Integrating Anion-π<sup>+</sup> Interaction and Crowded Conformation to Develop Multifunctional NIR AIEgen for Effective Tumor Theranostics via Hippo-YAP Pathway
Shiping Yang, Hongchi Yu, Junkai Liu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 1, 1997
Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections: results of a randomized, controlled clinical trial
J T Li, Y Lu, J Hou, et al.
Nature Biotechnology
|
September 25, 2023
Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses
Menglin Wang, Benoit Rousseau, Kunyu Qiu, et al.
Page
of 11